Back to the Top
The following message was posted to: PharmPK
Dear all,
have you experience about metabolic stability of fluorobenzoxy
derivatives? I suspect they are CYP3A substrates, like shown for the
benzyloxy-substituted of lactone cyclooxygenase inhibitor DFP by Deborah
A. Nicoll-Griffith and coworkers in DMD 32: 1509-1515, 2004.
Have you suggestions and or references?
Thanks in advance
Best regards
Stefano Porzio
Inpharzam Ricerche
Zambongroup
Switzerland
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)